Cinaciguat
Cinaciguat (BAY 58-2667) is a pioneering soluble guanylate cyclase (sGC) activator developed for treating acute decompensated heart failure. It is widely used in cardiovascular research to study sGC function and hemodynamics in both in vitro assays and in vivo heart failure models.
Product Specifications
CAS Number
329773-35-5
Product Name Alternative
Inhibit, Inhibitor, Guanylatecyclase, guanylate cyclase, Guanylate Cyclase, Guanylate cyclase, Cinaciguat, BAY 58-2667
Field of Research
Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:45 mg/mL (79.55 mM) ;10% DMSO+90% Corn Oil:2 mg/mL (3.54 mM)
Smiles
O (CC1=CC=C (CCC2=CC=CC=C2) C=C1) C3=C (CCN (CC4=CC=C (C (O) =O) C=C4) CCCCC (O) =O) C=CC=C3
Molecular Formula
C36H39NO5
Molecular Weight
565.7
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal IZUMO1 Antibody [HRP]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
bs-7647R-APC-Cy5.5 100 µL
VDAC3 Polyclonal Antibody, APC-Cy5.5 Conjugated
Sign In for Pricing
View Details K1710905 3x 1.0 µg
PPY sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 